IC
NVCR icon

IEQ Capital’s NovoCure NVCR Stock Holding History

IEQ Capital’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.17M Sell
274,961
-39,773
-13% -$602K 0.02% 556
2026
Q1 		$3.43M Sell
314,734
-64,240
-17% -$802K 0.02% 596
2025
Q4 		$4.9M Buy
378,974
+322,295
+569% +$4.14M 0.01% 528
2025
Q3 		$732K Buy
56,679
+8,130
+17% +$109K ﹤0.01% 1132
2025
Q2 		$864K Buy
+48,549
New +$846K 0.01% 905

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

IEQ Capital's NVCR Position: Q2 2026 in Review

IEQ Capital reduced its NovoCure (NVCR) stake by 13% in Q2 2026, selling an estimated $602K and leaving 274,961 shares worth $4.17M. The position accounts for 0.02% of the portfolio, ranked #556.

IEQ Capital first reported a position in NVCR in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.9M in Q4 2025. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • IEQ Capital held 274,961 shares of NovoCure worth $4.17M as of Q2 2026.
  • IEQ Capital sold 39,773 NovoCure shares in Q2 2026, an estimated $602K.
  • NovoCure made up 0.02% of IEQ Capital's portfolio in Q2 2026, its #556 holding.
  • IEQ Capital first reported a position in NovoCure in Q2 2025 and has held it in 5 quarters since.
  • IEQ Capital's NovoCure position peaked at $4.9M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.